These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 20961266)

  • 1. Relation between expression of α(1)-adrenoceptor mRNAs in bladder mucosa and urodynamic findings in men with lower urinary tract symptoms.
    Kurizaki Y; Ishizuka O; Imamura T; Ichino M; Ogawa T; Igawa Y; Nishizawa O; Andersson KE
    Scand J Urol Nephrol; 2011 Feb; 45(1):15-9. PubMed ID: 20961266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between expression of β3-adrenoceptor mRNA in bladder mucosa and urodynamic findings in men with lower urinary tract symptoms.
    Kurizaki Y; Ishizuka O; Imamura T; Ishikawa M; Ichino M; Ogawa T; Nishizawa O; Andersson KE
    Neurourol Urodyn; 2013 Jan; 32(1):88-91. PubMed ID: 22692629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association among the symptoms, quality of life and urodynamic parameters in patients with improved lower urinary tract symptoms following a transurethral resection of the prostate.
    Seki N; Yunoki T; Tomoda T; Takei M; Yamaguchi A; Naito S
    Neurourol Urodyn; 2008; 27(3):222-5. PubMed ID: 17580358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between expression of α₁-adrenoceptor subtype mRNA and severity of lower urinary tract symptoms or bladder outlet obstruction in benign prostatic hyperplasia patients.
    Kojima Y; Sasaki S; Imura M; Kubota Y; Hayashi Y; Kohri K
    BJU Int; 2011 Feb; 107(3):438-42. PubMed ID: 20804477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urodynamic effects of silodosin, a new alpha 1A-adrenoceptor selective antagonist, for the treatment of benign prostatic hyperplasia.
    Yamanishi T; Mizuno T; Tatsumiya K; Watanabe M; Kamai T; Yoshida K
    Neurourol Urodyn; 2010 Apr; 29(4):558-62. PubMed ID: 19693954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Bladder Neck and Urethral Sphincter Dysfunction in Men with Persistent Bothersome Lower Urinary Tract Symptoms after α-1 Blocker Treatment.
    Ke QS; Jiang YH; Kuo HC
    Low Urin Tract Symptoms; 2015 Sep; 7(3):143-8. PubMed ID: 26663729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of two alpha1-adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: a randomized crossover study.
    Nishino Y; Masue T; Miwa K; Takahashi Y; Ishihara S; Deguchi T
    BJU Int; 2006 Apr; 97(4):747-51, discussion 751. PubMed ID: 16536766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of short-term overactive bladder symptom improvement after transurethral resection of prostate in men with benign prostatic obstruction.
    Zhao YR; Liu WZ; Guralnick M; Niu WJ; Wang Y; Sun G; Xu Y
    Int J Urol; 2014 Oct; 21(10):1035-40. PubMed ID: 24825248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgens and bladder outlet obstruction: a correlation with pressure-flow variables in a preliminary study.
    Koritsiadis G; Stravodimos K; Mitropoulos D; Doumanis G; Fokitis I; Koritsiadis S; Constantinides C
    BJU Int; 2008 Jun; 101(12):1542-6. PubMed ID: 18294304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Add-on fesoterodine for residual storage symptoms suggestive of overactive bladder in men receiving α-blocker treatment for lower urinary tract symptoms.
    Kaplan SA; Roehrborn CG; Gong J; Sun F; Guan Z
    BJU Int; 2012 Jun; 109(12):1831-40. PubMed ID: 21966995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation Between Bladder Mucosal Alpha-1D/Alpha-1A Adrenoceptor mRNA Ratio and Lower Urinary Tract Function in Benign Prostatic Obstruction Patients.
    Kurizaki Y; Ishizuka O; Imamura T; Ichino M; Ishikawa M; Ogawa T; Nishizawa O
    Low Urin Tract Symptoms; 2013 May; 5(2):60-4. PubMed ID: 26663371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The resolution of detrusor over activity after medical and surgical treatment in patients with bladder outlet obstruction.
    Sriplakich S; Promwatcharanon K
    J Med Assoc Thai; 2007 Nov; 90(11):2326-31. PubMed ID: 18181315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naftopidil and propiverine hydrochloride for treatment of male lower urinary tract symptoms suggestive of benign prostatic hyperplasia and concomitant overactive bladder: a prospective randomized controlled study.
    Yokoyama T; Uematsu K; Watanabe T; Sasaki K; Kumon H; Nagai A;
    Scand J Urol Nephrol; 2009; 43(4):307-14. PubMed ID: 19396723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A quantitative analysis of mRNA expression of alpha 1 and beta-adrenoceptor subtypes and their functional roles in human normal and obstructed bladders.
    Nomiya M; Yamaguchi O
    J Urol; 2003 Aug; 170(2 Pt 1):649-53. PubMed ID: 12853849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of transurethral resection of the prostate in the patients with weak bladder contractility index.
    Han DH; Jeong YS; Choo MS; Lee KS
    Urology; 2008 Apr; 71(4):657-61. PubMed ID: 18313105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential mechanisms of action of superselective alpha(1)-adrenoceptor antagonists.
    Price D
    Eur Urol; 2001; 40 Suppl 4():5-11. PubMed ID: 11786674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An observational urodynamic evaluation of men with lower urinary tract symptoms treated with doxazosin.
    Gerber GS; Kim JH; Contreras BA; Steinberg GD; Rukstalis DB
    Urology; 1996 Jun; 47(6):840-4. PubMed ID: 8677574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is benign prostatic obstruction surgery indicated for improving overactive bladder symptoms in men with lower urinary tract symptoms?
    Cornu JN; Grise P
    Curr Opin Urol; 2016 Jan; 26(1):17-21. PubMed ID: 26574877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α(1)-Adrenoceptors in the urinary tract.
    Yamada S; Ito Y
    Handb Exp Pharmacol; 2011; (202):283-306. PubMed ID: 21290232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower urinary tract symptoms and bladder control in advanced Parkinson's disease: effects of deep brain stimulation in the subthalamic nucleus.
    Winge K; Nielsen KK; Stimpel H; Lokkegaard A; Jensen SR; Werdelin L
    Mov Disord; 2007 Jan; 22(2):220-5. PubMed ID: 17133504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.